Call on July 20 will include a snapshot from the ongoing InSight open-label extension study of sepofarsen, including preliminary second eye treatment data
Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General Counsel and is nominated to Management BoardGerard Platenburg to assume Chief Scientific Officer role, with le
… ProQR Announces Results for the Fourth Quarter and Full Year … and full year 2015. “2015 was a year of execution for ProQR. From the inception of ProQR in 2012, we had been … study is also assessing sweat chloride, weight gain, CFQ-R Respiratory Symptom Score and lung function, measured by …